WallStreetZenWallStreetZen

NASDAQ: REGN
Regeneron Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for REGN

Based on 17 analysts offering 12 month price targets for Regeneron Pharmaceuticals Inc.
Min Forecast
$650.00-20.89%
Avg Forecast
$884.24+7.61%
Max Forecast
$1,040.00+26.57%

Should I buy or sell REGN stock?

Based on 18 analysts offering ratings for Regeneron Pharmaceuticals Inc.
Buy
Strong Buy
9 analysts 50%
Buy
4 analysts 22.22%
Hold
3 analysts 16.67%
Sell
2 analysts 11.11%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their REGN stock forecasts and price targets.

REGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
JP Morgan
Bottom 26%
26
Strong BuyMaintains$950.00+15.62%2023-03-31
Bank of America
Top 20%
81
SellMaintains$650.00-20.89%2023-03-29
SVB Leerink
Top 10%
91
BuyUpgrades$976.00+18.78%2023-03-27
BMO Capital
Bottom 29%
29
BuyMaintains$1,040.00+26.57%2023-03-24
Baird
Top 22%
79
HoldMaintains$800.00-2.64%2023-03-24
Wells Fargo
Top 11%
90
Strong BuyMaintains$915.00+11.36%2023-03-24
Barclays
Bottom 16%
16
Strong BuyMaintains$915.00+11.36%2023-03-24
Jefferies
Top 22%
79
Strong BuyUpgrades$925.00+12.58%2023-03-24
EF Hutton
Bottom 11%
11
Strong BuyMaintains$862.00+4.91%2023-03-23
BMO Capital
Bottom 15%
15
BuyMaintains$1,025.00+24.75%2023-03-14

1 of 2

REGN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
REGN$821.67$884.24+7.61%Buy
VRTX$315.07$325.75+3.39%Buy
MRNA$153.58$201.20+31.01%Buy
SGEN$202.47$187.78-7.26%Buy
BNTX$124.57$170.89+37.18%Buy

Regeneron Pharmaceuticals Stock Forecast FAQ

Is Regeneron Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 18 Wall Street analysts covering (NASDAQ: REGN) stock is to Buy REGN stock.

Out of 18 analysts, 9 (50%) are recommending REGN as a Strong Buy, 4 (22.22%) are recommending REGN as a Buy, 3 (16.67%) are recommending REGN as a Hold, 2 (11.11%) are recommending REGN as a Sell, and 0 (0%) are recommending REGN as a Strong Sell.

If you're new to stock investing, here's how to buy Regeneron Pharmaceuticals stock.

What is REGN's Price Target?

According to 17 Wall Street analysts that have issued a 1 year REGN price target, the average REGN price target is $884.24, with the highest REGN stock price forecast at $1,040.00 and the lowest REGN stock price forecast at $650.00.

On average, Wall Street analysts predict that Regeneron Pharmaceuticals's share price could reach $884.24 by Mar 31, 2024. The average Regeneron Pharmaceuticals stock price prediction forecasts a potential upside of 7.61% from the current REGN share price of $821.67.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.